{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:24:29Z","timestamp":1783700669096,"version":"3.55.0"},"reference-count":294,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft (DFG)","doi-asserted-by":"publisher","award":["665271"],"award-info":[{"award-number":["665271"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Recent research into laminopathic lipodystrophies\u2014rare genetic disorders caused by mutations in the LMNA gene\u2014has greatly expanded our knowledge of their complex pathology and metabolic implications. These disorders, including Hutchinson-Gilford progeria syndrome (HGPS), Mandibuloacral Dysplasia (MAD), and Familial Partial Lipodystrophy (FPLD), serve as crucial models for studying accelerated aging and metabolic dysfunction, enhancing our understanding of the cellular and molecular mechanisms involved. Research on laminopathies has highlighted how LMNA mutations disrupt adipose tissue function and metabolic regulation, leading to altered fat distribution and metabolic pathway dysfunctions. Such insights improve our understanding of the pathophysiological interactions between genetic anomalies and metabolic processes. This review merges current knowledge on the phenotypic classifications of these diseases and their associated metabolic complications, such as insulin resistance, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome, all of which elevate the risk of cardiovascular disease, stroke, and diabetes. Additionally, a range of published therapeutic strategies, including gene editing, antisense oligonucleotides, and novel pharmacological interventions aimed at addressing defective adipocyte differentiation and lipid metabolism, will be explored. These therapies target the core dysfunctional lamin A protein, aiming to mitigate symptoms and provide a foundation for addressing similar metabolic and genetic disorders.<\/jats:p>","DOI":"10.3390\/ijms25158020","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T14:26:50Z","timestamp":1721744810000},"page":"8020","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Navigating Lipodystrophy: Insights from Laminopathies and Beyond"],"prefix":"10.3390","volume":"25","author":[{"given":"Peter","family":"Kr\u00fcger","sequence":"first","affiliation":[{"name":"Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Munich Institute of Biomedical Engineering (MIBE), Technical University of Munich (TUM), 85748 Garching, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Hartinger","sequence":"additional","affiliation":[{"name":"Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Munich Institute of Biomedical Engineering (MIBE), Technical University of Munich (TUM), 85748 Garching, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4067-4977","authenticated-orcid":false,"given":"Karima","family":"Djabali","sequence":"additional","affiliation":[{"name":"Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Munich Institute of Biomedical Engineering (MIBE), Technical University of Munich (TUM), 85748 Garching, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40618-018-0887-z","article-title":"Diagnosis and treatment of lipodystrophy: A step-by-step approach","volume":"42","author":"Santini","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2337\/diacare.26.6.1819","article-title":"K\u00f6bberling type of familial partial lipodystrophy: An underrecognized syndrome","volume":"26","author":"Herbst","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and Inherited Lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev.me.44.020193.001005","article-title":"Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition","volume":"44","author":"Reaven","year":"1993","journal-title":"Annu. Rev. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16321","DOI":"10.1016\/S0021-9258(19)85424-8","article-title":"Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C","volume":"268","author":"Lin","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/19491034.2017.1337622","article-title":"The structure of lamin filaments in somatic cells as revealed by cryo-electron tomography","volume":"8","author":"Turgay","year":"2017","journal-title":"Nucleus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2017.04.022","article-title":"Lamina-Associated Domains: Links with Chromosome Architecture, Heterochromatin, and Gene Repression","volume":"169","author":"Belmont","year":"2017","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1101\/gr.141028.112","article-title":"Constitutive nuclear lamina-genome interactions are highly conserved and associated with A\/T-rich sequence","volume":"23","author":"Meuleman","year":"2013","journal-title":"Genome Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nature06947","article-title":"Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions","volume":"453","author":"Guelen","year":"2008","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e77740","DOI":"10.7554\/eLife.77740","article-title":"Discovery and functional assessment of a novel adipocyte population driven by intracellular Wnt\/\u03b2-catenin signaling in mammals","volume":"11","author":"Liu","year":"2022","journal-title":"Elife"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101073","DOI":"10.1016\/j.arr.2020.101073","article-title":"Lamin A involvement in ageing processes","volume":"62","author":"Cenni","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cell.2013.01.009","article-title":"LBR and lamin A\/C sequentially tether peripheral heterochromatin and inversely regulate differentiation","volume":"152","author":"Solovei","year":"2013","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1038\/ncomms9044","article-title":"Loss of lamin A function increases chromatin dynamics in the nuclear interior","volume":"6","author":"Bronshtein","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcn\/45.1.277","article-title":"Adipose tissue as a source of hormones","volume":"45","author":"Siiteri","year":"1987","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose Tissue as an Endocrine Organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s13340-015-0212-4","article-title":"Glucose area under the curve during oral glucose tolerance test as an index of glucose intolerance","volume":"7","author":"Sakaguchi","year":"2015","journal-title":"Diabetol. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","article-title":"Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human","volume":"150","author":"Wu","year":"2012","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1079\/PNS19920050","article-title":"An evolutionary and functional view of mammalian adipose tissue","volume":"51","author":"Pond","year":"1992","journal-title":"Proc. Nutr. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000321319","article-title":"Brown versus White Adipose Tissue: A Mini-Review","volume":"58","author":"Saely","year":"2012","journal-title":"Gerontology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-12-800280-3.00012-8","article-title":"Chapter Twelve\u2014Methods for Performing Lipidomics in White Adipose Tissue","volume":"Volume 538","author":"MacDougald","year":"2014","journal-title":"Methods in Enzymology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cell.2007.10.004","article-title":"Developmental Origin of Fat: Tracking Obesity to Its Source","volume":"131","author":"Gesta","year":"2007","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1152\/physrev.1994.74.4.761","article-title":"Regional adiposity and morbidity","volume":"74","author":"Kissebah","year":"1994","journal-title":"Physiol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature05894","article-title":"Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance","volume":"447","author":"Odegaard","year":"2007","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"E439","DOI":"10.1002\/oby.20135","article-title":"Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults","volume":"21","author":"Neeland","year":"2013","journal-title":"Obesity"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00125-002-0873-y","article-title":"Adipose tissue as a buffer for daily lipid flux","volume":"45","author":"Frayn","year":"2002","journal-title":"Diabetologia"},{"key":"ref_29","first-page":"338","article-title":"Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome\u2014An allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Biol. Lipids"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.1230721","article-title":"Pleiotropic Actions of Insulin Resistance and Inflammation in Metabolic Homeostasis","volume":"339","author":"Odegaard","year":"2013","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI34260","article-title":"Insulin sensitivity: Modulation by nutrients and inflammation","volume":"118","author":"Schenk","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, Inflammation, and Insulin Resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2337\/diabetes.54.10.2939","article-title":"Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation","volume":"54","author":"Plomgaard","year":"2005","journal-title":"Diabetes"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/art.40161","article-title":"Conditional Macrophage Depletion Increases Inflammation and Does Not Inhibit the Development of Osteoarthritis in Obese Macrophage Fas-Induced Apoptosis-Transgenic Mice","volume":"69","author":"Wu","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: A road to inflammation","volume":"23","author":"Bertrand","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1194\/jlr.M800019-JLR200","article-title":"Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice","volume":"49","author":"Murano","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/sj.cdd.4402127","article-title":"Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin\/TCF4(TCF7L2)-dependent pathway","volume":"14","author":"Cawthorn","year":"2007","journal-title":"Cell Death Differ."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0026-0495(95)90311-9","article-title":"Macronutrients and energy balance in obesity","volume":"44","author":"Schutz","year":"1995","journal-title":"Metab.\u2014Clin. Exp."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/21623945.2017.1319535","article-title":"Quantification of UCP1 function in human brown adipose tissue","volume":"6","author":"Porter","year":"2017","journal-title":"Adipocyte"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1005440221914","article-title":"Uncoupling protein--a useful energy dissipator","volume":"31","author":"Klingenberg","year":"1999","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown Adipose Tissue: Function and Physiological Significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol. Rev."},{"key":"ref_43","unstructured":"del Moral, A.M., and Aguilera Garc\u00eda, C.M. (2018). Chapter 4\u2014Inflammation and Oxidative Stress in Adipose Tissue: Nutritional Regulation. Obesity, Academic Press."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1101\/gad.211649.112","article-title":"Adaptive thermogenesis in adipocytes: Is beige the new brown?","volume":"27","author":"Wu","year":"2013","journal-title":"Genes Dev."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"El Hadi, H., Di Vincenzo, A., Vettor, R., and Rossato, M. (2019). Food Ingredients Involved in White-to-Brown Adipose Tissue Conversion and in Calorie Burning. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.01954"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2330249","article-title":"Glucose utilization in vivo and insulin-sensitivity of rat brown adipose tissue in various physiological and pathological conditions","volume":"233","author":"Burnol","year":"1986","journal-title":"Biochem. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"107547","DOI":"10.1016\/j.celrep.2020.107547","article-title":"The Autophagy-Initiating Kinase ULK1 Controls RIPK1-Mediated Cell Death","volume":"31","author":"Wu","year":"2020","journal-title":"Cell Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1210\/endo.139.3.5854","article-title":"Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes","volume":"139","author":"Valverde","year":"1998","journal-title":"Endocrinology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.2527\/jas.2007-0462","article-title":"Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes","volume":"86","author":"Lorenzo","year":"2008","journal-title":"J. Anim. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"E676","DOI":"10.1152\/ajpendo.00028.2015","article-title":"Macrophage infiltration into obese adipose tissues suppresses the induction of UCP1 level in mice","volume":"310","author":"Sakamoto","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"C918","DOI":"10.1152\/ajpcell.00249.2013","article-title":"Activation of pattern recognition receptors in brown adipocytes induces inflammation and suppresses uncoupling protein 1 expression and mitochondrial respiration","volume":"306","author":"Bae","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s10753-017-0718-y","article-title":"Inhibitory Effects of Toll-Like Receptor 4, NLRP3 Inflammasome, and Interleukin-1\u03b2 on White Adipocyte Browning","volume":"41","author":"Okla","year":"2018","journal-title":"Inflammation"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"N\u00f8hr, M.K., Bobba, N., Richelsen, B., Lund, S., and Pedersen, S.B. (2017). Inflammation Downregulates UCP1 Expression in Brown Adipocytes Potentially via SIRT1 and DBC1 Interaction. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18051006"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(01)02264-5","article-title":"TNF-alpha inhibits UCP-1 expression in brown adipocytes via ERKs. Opposite effect of p38MAPK","volume":"493","author":"Valladares","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cyto.2015.11.001","article-title":"Proinflammatory cytokine interleukin-1\u03b2 suppresses cold-induced thermogenesis in adipocytes","volume":"77","author":"Goto","year":"2016","journal-title":"Cytokine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.1210\/jc.2013-3555","article-title":"Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes","volume":"99","author":"White","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/oby.21679","article-title":"Oncostatin m impairs brown adipose tissue thermogenic function and the browning of subcutaneous white adipose tissue","volume":"25","author":"Cereijo","year":"2017","journal-title":"Obesity"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.bbalip.2016.07.002","article-title":"Brown adipose tissue in obesity: Fractalkine-receptor dependent immune cell recruitment affects metabolic-related gene expression","volume":"1861","author":"Winkler","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/nm.4422","article-title":"Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine","volume":"23","author":"Pirzgalska","year":"2017","journal-title":"Nat. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature24022","article-title":"Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing","volume":"550","author":"Camell","year":"2017","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2016.06.012","article-title":"Lipodystrophy Syndromes","volume":"45","author":"Hussain","year":"2016","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/0470093765.ch11","article-title":"A-type lamin-linked lipodystrophies","volume":"264","author":"Vigouroux","year":"2005","journal-title":"Novartis Found. Symp."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/B978-0-444-62702-5.00018-4","article-title":"Hutchinson-Gilford progeria syndrome","volume":"132","author":"Ullrich","year":"2015","journal-title":"Handb. Clin. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/ajmg.a.31346","article-title":"Hutchinson\u2013Gilford progeria syndrome: Review of the phenotype","volume":"140","author":"Hennekam","year":"2006","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3476(72)80229-4","article-title":"The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature","volume":"80","author":"DeBusk","year":"1972","journal-title":"J. Pediatr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMoa0706898","article-title":"Phenotype and course of Hutchinson-Gilford progeria syndrome","volume":"358","author":"Merideth","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin A Truncation in Hutchinson-Gilford Progeria","volume":"300","author":"Bernard","year":"2003","journal-title":"Science"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(03)14069-X","article-title":"LMNA mutations in atypical Werner\u2019s syndrome","volume":"362","author":"Chen","year":"2003","journal-title":"Lancet"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.yexcr.2011.09.012","article-title":"Subcellular localization of SREBP1 depends on its interaction with the C-terminal region of wild-type and disease related A-type lamins","volume":"317","author":"Woerner","year":"2011","journal-title":"Exp. Cell Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI1411","article-title":"Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1\/SREBP1","volume":"101","author":"Kim","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18632\/aging.100550","article-title":"An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells","volume":"5","author":"Xiong","year":"2013","journal-title":"Aging"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"bvaa108","DOI":"10.1210\/jendso\/bvaa108","article-title":"Atypical Progeroid Syndrome and Partial Lipodystrophy Due to LMNA Gene p.R349W Mutation","volume":"4","author":"Magno","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1172\/JCI129190","article-title":"What lipodystrophies teach us about the metabolic syndrome","volume":"129","author":"Mann","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1017\/S1462399410001547","article-title":"Molecular mechanisms controlling human adipose tissue development: Insights from monogenic lipodystrophies","volume":"12","author":"Rochford","year":"2010","journal-title":"Expert. Rev. Mol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/19491034.2018.1456217","article-title":"Lipodystrophic syndromes due to LMNA mutations: Recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives","volume":"9","author":"Vigouroux","year":"2018","journal-title":"Nucleus"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1038\/s41598-017-04492-0","article-title":"Rare progerin-expressing preadipocytes and adipocytes contribute to tissue depletion over time","volume":"7","author":"Viceconte","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.exger.2004.02.002","article-title":"Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis","volume":"39","author":"Bridger","year":"2004","journal-title":"Exp. Gerontol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1242\/jcs.022913","article-title":"Targeted transgenic expression of the mutation causing Hutchinson-Gilford progeria syndrome leads to proliferative and degenerative epidermal disease","volume":"121","author":"Sagelius","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/19491034.2018.1460045","article-title":"An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome","volume":"9","author":"Harhouri","year":"2018","journal-title":"Nucleus"},{"key":"ref_82","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (1993). Hutchinson-Gilford Progeria Syndrome. GeneReviews(\u00ae), University of Washington."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2147\/DMSO.S206053","article-title":"Familial Partial Lipodystrophy (FPLD): Recent Insights","volume":"13","author":"Bagias","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_84","unstructured":"Jameson, J.L., De Groot, L.J., de Kretser, D.M., Giudice, L.C., Grossman, A.B., Melmed, S., Potts, J.T., and Weir, G.C. (2016). Chapter 37\u2014Lipodystrophy Syndromes. Endocrinology: Adult and Pediatric, W.B. Saunders. [7th ed.]."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2017.12.001","article-title":"Mandibuloacral dysplasia: A premature ageing disease with aspects of physiological ageing","volume":"42","author":"Cenni","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","article-title":"Lipodystrophy: Pathophysiology and advances in treatment","volume":"7","author":"Fiorenza","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13023-019-1269-0","article-title":"Mandibuloacral dysplasia type B (MADB): A cohort of eight patients from Suriname with a homozygous founder mutation in ZMPSTE24 (FACE1), clinical diagnostic criteria and management guidelines","volume":"14","author":"Hitzert","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1210\/jcem.80.12.8530581","article-title":"An unusual type of familial lipodystrophy","volume":"80","author":"Johansen","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.23.2.120","article-title":"Familial partial lipodystrophy: Two types of an X linked dominant syndrome, lethal in the hemizygous state","volume":"23","author":"Dunnigan","year":"1986","journal-title":"J. Med. Genet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Clinical review#: Lipodystrophies: Genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: Comparison of baseline characteristics and response to metreleptin","volume":"100","author":"Cochran","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy","volume":"364","author":"Gandotra","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/emmm.200900037","article-title":"Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC","volume":"1","author":"Puri","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajmg.a.37880","article-title":"Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy","volume":"173","author":"Zolotov","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mus.24157","article-title":"Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin","volume":"49","author":"Carboni","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-7-3","article-title":"Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia","volume":"7","author":"Cao","year":"2008","journal-title":"Lipids Health Dis"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"A family with severe insulin resistance and diabetes due to a mutation in AKT2","volume":"304","author":"George","year":"2004","journal-title":"Science"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajhg.2011.04.010","article-title":"Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome","volume":"88","author":"Puente","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1258\/095646202320753682","article-title":"Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy","volume":"13","author":"Batterham","year":"2002","journal-title":"Int. J. STD AIDS"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QAI.0b013e318158c0a6","article-title":"Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy","volume":"46","author":"Mutimura","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_102","unstructured":"Guzman, N., and Vijayan, V. (2024). HIV-Associated Lipodystrophy. StatPearls, StatPearls Publishing Copyright \u00a9 2024; StatPearls Publishing LLC."},{"key":"ref_103","first-page":"1","article-title":"The role of cellular senescence in skin aging","volume":"3","author":"Campisi","year":"1998","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000316893","article-title":"Human lipodystrophies: Genetic and acquired diseases of adipose tissue","volume":"19","author":"Capeau","year":"2010","journal-title":"Endocr. Dev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2006.12.190","article-title":"Attenuation of obesity-induced adipose tissue inflammation in C3H\/HeJ mice carrying a Toll-like receptor 4 mutation","volume":"354","author":"Suganami","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Najdi, F., Kr\u00fcger, P., and Djabali, K. (2021). Impact of Progerin Expression on Adipogenesis in Hutchinson-Gilford Progeria Skin-Derived Precursor Cells. Cells, 10.","DOI":"10.3390\/cells10071598"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/ncb1708","article-title":"Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing","volume":"10","author":"Scaffidi","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2010.12.002","article-title":"A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects","volume":"8","author":"Zhang","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e13175","DOI":"10.1111\/acel.13175","article-title":"Progress and trends in the development of therapies for Hutchinson\u2013Gilford progeria syndrome","volume":"19","author":"Lai","year":"2020","journal-title":"Aging Cell"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nm1786","article-title":"Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging","volume":"14","author":"Varela","year":"2008","journal-title":"Nat. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.116.022188","article-title":"Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome","volume":"134","author":"Gordon","year":"2016","journal-title":"Circulation"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41591-019-0343-4","article-title":"Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome","volume":"25","author":"Beyret","year":"2019","journal-title":"Nat. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/1872208315666210928114720","article-title":"Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr\/Cas Technology as A Promising Innovative Treatment Approach","volume":"15","author":"Rajeev","year":"2021","journal-title":"Recent. Pat. Biotechnol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41591-021-01274-0","article-title":"A targeted antisense therapeutic approach for Hutchinson-Gilford progeria syndrome","volume":"27","author":"Erdos","year":"2021","journal-title":"Nat. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","article-title":"In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice","volume":"589","author":"Koblan","year":"2021","journal-title":"Nature"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1073\/pnas.1910972116","article-title":"ATP-based therapy prevents vascular calcification and extends longevity in a mouse model of Hutchinson-Gilford progeria syndrome","volume":"116","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Benarroch, L., Cohen, E., Atalaia, A., Ben Yaou, R., Bonne, G., and Bertrand, A.T. (2021). Preclinical Advances of Therapies for Laminopathies. J. Clin. Med., 10.","DOI":"10.3390\/jcm10214834"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"106ra107","DOI":"10.1126\/scitranslmed.3002847","article-title":"Splicing-directed therapy in a new mouse model of human accelerated aging","volume":"3","author":"Osorio","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1172\/JCI85908","article-title":"Modulation of LMNA splicing as a strategy to treat prelamin A diseases","volume":"126","author":"Lee","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Harhouri, K., Navarro, C., Baquerre, C., Da Silva, N., Bartoli, C., Casey, F., Mawuse, G.K., Doubaj, Y., L\u00e9vy, N., and De Sandre-Giovannoli, A. (2016). Antisense-Based Progerin Downregulation in HGPS-Like Patients\u2019 Cells. Cells, 5.","DOI":"10.3390\/cells5030031"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e12979","DOI":"10.1111\/acel.12979","article-title":"Transient introduction of human telomerase mRNA improves hallmarks of progeria cells","volume":"18","author":"Li","year":"2019","journal-title":"Aging Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000368856","article-title":"Restoring SIRT6 Expression in Hutchinson-Gilford Progeria Syndrome Cells Impedes Premature Senescence and Formation of Dysmorphic Nuclei","volume":"82","author":"Endisha","year":"2015","journal-title":"Pathobiology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/hmg\/ddg213","article-title":"Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia","volume":"12","author":"Agarwal","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/341908","article-title":"Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A\/C","volume":"71","author":"Novelli","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1210\/jcem.87.2.8258","article-title":"Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia","volume":"87","author":"Simha","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1152\/physiolgenomics.00060.2005","article-title":"Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy","volume":"23","author":"Filesi","year":"2005","journal-title":"Physiol. Genom."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/hmg\/11.7.769","article-title":"A novel interaction between lamin A and SREBP1: Implications for partial lipodystrophy and other laminopathies","volume":"11","author":"Lloyd","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2265.2007.02870.x","article-title":"Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism","volume":"67","author":"Vantyghem","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Chiarini, F., Evangelisti, C., Cenni, V., Fazio, A., Paganelli, F., Martelli, A.M., and Lattanzi, G. (2019). The Cutting Edge: The Role of mTOR Signaling in Laminopathies. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040847"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0289-0","article-title":"Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: An in vitro and in vivo study of adipose tissue browning","volume":"51","author":"Pellegrini","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pathol.2018.11.004","article-title":"Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease","volume":"51","author":"Hussain","year":"2019","journal-title":"Pathology"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Fernandez-Pombo, A., Diaz-Lopez, E.J., Castro, A.I., Sanchez-Iglesias, S., Cobelo-Gomez, S., Prado-Mora\u00f1a, T., and Araujo-Vilar, D. (2023). Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review. Cells, 12.","DOI":"10.3390\/cells12050725"},{"key":"ref_133","first-page":"249","article-title":"Lipodystrophic laminopathies: Diagnostic clues","volume":"9","year":"2018","journal-title":"Nucleus"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12020-016-1002-x","article-title":"Type 1 familial partial lipodystrophy: Understanding the K\u00f6bberling syndrome","volume":"54","author":"Pazos","year":"2016","journal-title":"Endocrine"},{"key":"ref_135","first-page":"170","article-title":"Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety)","volume":"84","author":"Garg","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/db14-0104","article-title":"Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy","volume":"64","author":"Kozusko","year":"2015","journal-title":"Diabetes"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-011-2142-4","article-title":"Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPAR\u03b3 mutation (Y151C)","volume":"54","author":"Visser","year":"2011","journal-title":"Diabetologia"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/DMSO.S130810","article-title":"Estimating the prevalence of generalized and partial lipodystrophy: Findings and challenges","volume":"10","author":"Chiquette","year":"2017","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Rutkowska, L., Salachna, D., Lewandowski, K., Lewi\u0144ski, A., and Gach, A. (2022). Familial Partial Lipodystrophy-Literature Review and Report of a Novel Variant in PPARG Expanding the Spectrum of Disease-Causing Alterations in FPLD3. Diagnostics, 12.","DOI":"10.3390\/diagnostics12051122"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00125-004-1360-4","article-title":"Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene","volume":"47","author":"Savage","year":"2004","journal-title":"Diabetologia"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1093\/hmg\/ddl172","article-title":"Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation","volume":"15","author":"Verstraeten","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-133-4-200008150-00009","article-title":"Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes","volume":"133","author":"Arioglu","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_145","first-page":"EDM210082","article-title":"Rapid response to leptin therapy in a FPLD patient with a novel PPARG missense variant","volume":"2021","author":"Melzer","year":"2021","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/DDDT.S224771","article-title":"Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy","volume":"14","author":"Esan","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.atherosclerosis.2018.03.019","article-title":"New medications targeting triglyceride-rich lipoproteins: Can inhibition of ANGPTL3 or apoC-III reduce the residual cardiovascular risk?","volume":"272","author":"Olkkonen","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"E513","DOI":"10.1208\/aapsj070352","article-title":"Model-based development of gemcabene, a new lipid-altering agent","volume":"7","author":"Mandema","year":"2005","journal-title":"AAPS J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/ajmg.a.61777","article-title":"An additional case of N\u00e9stor-Guillermo progeria syndrome diagnosed in early childhood","volume":"182","author":"Fisher","year":"2020","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0735-6757(84)90131-1","article-title":"Acquired immunodeficiency syndrome (AIDS)","volume":"2","author":"Gong","year":"1984","journal-title":"Am. J. Emerg. Med."},{"key":"ref_152","first-page":"927","article-title":"Development of antiviral agents for the treatment of human immunodeficiency virus infection","volume":"6","author":"Tartaglione","year":"1987","journal-title":"Clin. Pharm."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.16.1.18567","article-title":"Non-nucleoside reverse transcriptase inhibitors: A review on pharmacokinetics, pharmacodynamics, safety and tolerability","volume":"16","author":"Usach","year":"2013","journal-title":"J. Int. AIDS Soc."},{"key":"ref_154","first-page":"332","article-title":"Protease Inhibitors for Patients With HIV-1 Infection: A Comparative Overview","volume":"36","author":"Hughes","year":"2011","journal-title":"Pharm. Ther."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1086\/313853","article-title":"HIV-1 Protease Inhibitors","volume":"30","author":"Eron","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ajcn\/68.3.519","article-title":"HIV infection: A model chronic illness for studying wasting diseases","volume":"68","author":"Kotler","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41572-020-0181-1","article-title":"HIV and antiretroviral therapy-related fat alterations","volume":"6","author":"Koethe","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/hsc.12459","article-title":"\u201cI don\u2019t want to look like an AIDS victim\u201d: A New Zealand case study of facial lipoatrophy","volume":"26","author":"Abel","year":"2018","journal-title":"Health Soc. Care Community"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"de Waal, R., Cohen, K., and Maartens, G. (2013). Systematic review of antiretroviral-associated lipodystrophy: Lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063623"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/157016210793499222","article-title":"Differential effects of efavirenz and lopinavir\/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines","volume":"8","author":"Domingo","year":"2010","journal-title":"Curr. HIV Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1152\/ajpendo.00056.2003","article-title":"Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy","volume":"286","author":"Johnson","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2015.12.012","article-title":"LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation","volume":"245","author":"Afonso","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Domingo, P., Gutierrez, M.d.M., Gallego-Escuredo, J.M., Torres, F., Mateo, G.M., Villarroya, J., de los Santos, I., Domingo, J.C., Villarroya, F., and Rio, L.D. (2014). Effects of Switching from Stavudine to Raltegravir on Subcutaneous Adipose Tissue in HIV-Infected Patients with HIV\/HAART-Associated Lipodystrophy Syndrome (HALS). A Clinical and Molecular Study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089088"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.0704212104","article-title":"HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells","volume":"104","author":"Coffinier","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"108228","DOI":"10.1016\/j.celrep.2020.108228","article-title":"MED19 Regulates Adipogenesis and Maintenance of White Adipose Tissue Mass by Mediating PPAR\u03b3-Dependent Gene Expression","volume":"33","author":"Dean","year":"2020","journal-title":"Cell Rep."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1467-789X.2006.00270.x","article-title":"The role of leptin and ghrelin in the regulation of food intake and body weight in humans: A review","volume":"8","author":"Klok","year":"2007","journal-title":"Obes. Rev."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/rp.59.1.305","article-title":"Leptin signaling in the central nervous system and the periphery","volume":"59","author":"Kahn","year":"2004","journal-title":"Recent. Prog. Horm. Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmet.2006.02.001","article-title":"Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: Neuronal involvement in food-intake regulation","volume":"3","author":"Yamada","year":"2006","journal-title":"Cell Metab."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12933-018-0777-x","article-title":"Perivascular adipose tissue (PVAT) in atherosclerosis: A double-edged sword","volume":"17","author":"Qi","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/ATVBAHA.114.303029","article-title":"Perivascular adipose tissue in vascular function and disease: A review of current research and animal models","volume":"34","author":"Brown","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2017.03.051","article-title":"Targeting white, brown and perivascular adipose tissue in atherosclerosis development","volume":"816","author":"Boon","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1089\/met.2017.0074","article-title":"Browning of Abdominal Aorta Perivascular Adipose Tissue Inhibits Adipose Tissue Inflammation","volume":"15","author":"Li","year":"2017","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1039\/C6FO01473A","article-title":"Gene expression modulation of lipid and central energetic metabolism related genes by high-fat diet intake in the main homeostatic tissues","volume":"8","author":"Palou","year":"2017","journal-title":"Food Funct."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cmet.2015.10.003","article-title":"Thermoneutral Housing Accelerates Metabolic Inflammation to Potentiate Atherosclerosis but Not Insulin Resistance","volume":"23","author":"Tian","year":"2016","journal-title":"Cell Metab."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.112.104489","article-title":"Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-\u03b3 deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis","volume":"126","author":"Chang","year":"2012","journal-title":"Circulation"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/ATVBAHA.116.308659","article-title":"Brown Adipose Tissue Regulates Small Artery Function Through NADPH Oxidase 4-Derived Hydrogen Peroxide and Redox-Sensitive Protein Kinase G-1\u03b1","volume":"37","author":"Persson","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Ayala-Lopez, N., Thompson, J.M., and Watts, S.W. (2017). Perivascular Adipose Tissue\u2019s Impact on Norepinephrine-Induced Contraction of Mesenteric Resistance Arteries. Front. Physiol., 8.","DOI":"10.3389\/fphys.2017.00037"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MOL.0000000000000522","article-title":"Relevance of human fat distribution on lipid and lipoprotein metabolism and cardiovascular disease risk","volume":"29","author":"Vasan","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1113\/JP273049","article-title":"The role of epicardial adipose tissue in cardiac biology: Classic concepts and emerging roles","volume":"595","author":"Antonopoulos","year":"2017","journal-title":"J. Physiol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.echo.2009.10.013","article-title":"Echocardiographic epicardial fat: A review of research and clinical applications","volume":"22","author":"Iacobellis","year":"2009","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ncpcardio0319","article-title":"Epicardial adipose tissue: Anatomic, biomolecular and clinical relationships with the heart","volume":"2","author":"Iacobellis","year":"2005","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"ref_182","first-page":"251","article-title":"Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease","volume":"29","author":"Iacobellis","year":"2005","journal-title":"Cytokine"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"E1448","DOI":"10.1210\/jc.2013-1265","article-title":"Adult epicardial fat exhibits beige features","volume":"98","author":"Sacks","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijcard.2016.11.074","article-title":"B\u2018rowning\u2019 the cardiac and peri-vascular adipose tissues to modulate cardiovascular risk","volume":"228","author":"Aldiss","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"15566","DOI":"10.1038\/s41598-017-15501-7","article-title":"Functional characterization of the Ucp1-associated oxidative phenotype of human epicardial adipose tissue","volume":"7","author":"Chechi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Villasante Fricke, A.C., and Iacobellis, G. (2019). Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235989"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"E1443","DOI":"10.1152\/ajpendo.00273.2007","article-title":"Expression of adrenomedullin in human epicardial adipose tissue: Role of coronary status","volume":"293","author":"Silaghi","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacc.2011.01.048","article-title":"Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue","volume":"58","author":"Hirata","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1536\/ihj.52.139","article-title":"Enhanced inflammation in epicardial fat in patients with coronary artery disease","volume":"52","author":"Hirata","year":"2011","journal-title":"Int. Heart J."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Bilski, J., Mazur-Bialy, A., Wojcik, D., Surmiak, M., Magierowski, M., Sliwowski, Z., Pajdo, R., Kwiecien, S., Danielak, A., and Ptak-Belowska, A. (2019). Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases. Biomolecules, 9.","DOI":"10.3390\/biom9120780"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"G659","DOI":"10.1152\/ajpgi.00079.2018","article-title":"Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice","volume":"315","author":"Wu","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_192","first-page":"305","article-title":"Cardiac Alterations in Patients with Familial Lipodystrophy","volume":"114","author":"Romano","year":"2020","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI29027","article-title":"Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony","volume":"116","author":"Herman","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice","volume":"269","author":"Pelleymounter","year":"1995","journal-title":"Science"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2337\/dc10-2083","article-title":"Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: Changes associated with pioglitazone","volume":"34","author":"Sacks","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.biochi.2012.04.014","article-title":"Early induction of a brown-like phenotype by rosiglitazone in the epicardial adipose tissue of fatty Zucker rats","volume":"94","author":"Distel","year":"2012","journal-title":"Biochimie"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1210\/jc.2017-01235","article-title":"Roux-en-Y Gastric Bypass Surgery in the Management of Familial Partial Lipodystrophy Type 1","volume":"102","author":"Melvin","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/dme.13527","article-title":"Insulin secretory defect in familial partial lipodystrophy Type 2 and successful long-term treatment with a glucagon-like peptide 1 receptor agonist","volume":"34","author":"Banning","year":"2017","journal-title":"Diabet. Med."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13098-017-0226-0","article-title":"Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2","volume":"9","author":"Valerio","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Hartinger, R., Lederer, E.M., Schena, E., Lattanzi, G., and Djabali, K. (2023). Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson-Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies. Cells, 12.","DOI":"10.3390\/cells12101350"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbalip.2007.11.003","article-title":"Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation","volume":"1781","author":"Yang","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"39741","DOI":"10.1074\/jbc.R600033200","article-title":"Prelamin A farnesylation and progeroid syndromes","volume":"281","author":"Young","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10522-019-09807-4","article-title":"Presence and distribution of progerin in HGPS cells is ameliorated by drugs that impact on the mevalonate and mTOR pathways","volume":"20","author":"Clements","year":"2019","journal-title":"Biogerontology"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.113.008285","article-title":"Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome","volume":"130","author":"Gordon","year":"2014","journal-title":"Circulation"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11883-019-0793-7","article-title":"Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients","volume":"21","author":"Strandberg","year":"2019","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1210\/clinem\/dgab193","article-title":"Cardiovascular Safety and Sclerostin Inhibition","volume":"106","author":"Langdahl","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","article-title":"Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome","volume":"109","author":"Gordon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_208","first-page":"1391","article-title":"New advances in the treatment of generalized lipodystrophy: Role of metreleptin","volume":"11","author":"Rodriguez","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cen.12980","article-title":"Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy","volume":"85","author":"Chan","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cyto.2018.10.012","article-title":"Beneficial effects of leptin substitution on impaired eating behavior in lipodystrophy are sustained beyond 150 weeks of treatment","volume":"113","author":"Miehle","year":"2019","journal-title":"Cytokine"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"e2953","DOI":"10.1210\/clinem\/dgab216","article-title":"Effect of Leptin Therapy on Survival in Generalized and Partial Lipodystrophy: A Matched Cohort Analysis","volume":"106","author":"Cook","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","article-title":"Efficacy of leptin therapy in the different forms of human lipodystrophy","volume":"53","author":"Chong","year":"2010","journal-title":"Diabetologia"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2337\/dc16-1553","article-title":"Efficacy and Safety of Metreleptin Therapy in Patients With Type 1 Diabetes: A Pilot Study","volume":"40","author":"Vasandani","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/jc.2018-02787","article-title":"Efficacy of Metreleptin Treatment in Familial Partial Lipodystrophy Due to PPARG vs. LMNA Pathogenic Variants","volume":"104","author":"Sekizkardes","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12020-019-01862-8","article-title":"Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy","volume":"64","author":"Oral","year":"2019","journal-title":"Endocrine"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/0970-258X.317476","article-title":"Metreleptin replacement treatment improves quality of life and psychological well-being in congenital generalized lipodystrophy","volume":"33","author":"Simsir","year":"2020","journal-title":"Natl. Med. J. India"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4274\/jcrpe.galenos.2022.2022-1-25","article-title":"Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year","volume":"15","author":"Demiral","year":"2023","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MOL.0000000000000354","article-title":"New oral agents for treating dyslipidemia","volume":"27","author":"Gryn","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-018-3353-5","article-title":"Gemcabene, a first-in-class lipid-lowering agent in late-stage development, down-regulates acute-phase C-reactive protein via C\/EBP-\u03b4-mediated transcriptional mechanism","volume":"449","author":"Srivastava","year":"2018","journal-title":"Mol. Cell Biochem."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Akinci, B., Swaidan, M., Foss-Freitas, M.C., Luo, Y., Neidert, A.H., Hench, R.P., Chenevert, T.L., Longcore, A., Bakker-Arkema, R., and Bisgaier, C.L. (2020). 2214-PUB: An Open-Label Study of Gemcabene in Adults with Familial Partial Lipodystrophy. Diabetes, 69.","DOI":"10.2337\/db20-2214-PUB"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for Homozygous Familial Hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4070\/kcj.2018.0343","article-title":"Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy","volume":"48","author":"Reiner","year":"2018","journal-title":"Korean Circ. J."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s40265-019-01168-z","article-title":"Volanesorsen: First Global Approval","volume":"79","author":"Paik","year":"2019","journal-title":"Drugs"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/eurheartj\/ehz209","article-title":"N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels","volume":"40","author":"Alexander","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"e9431","DOI":"10.15252\/emmm.201809431","article-title":"AAV-mediated gene therapy as a strategy to fight obesity and metabolic diseases","volume":"10","author":"Sponton","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"e8791","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"Jimenez","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09879","article-title":"Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome","volume":"472","author":"Liu","year":"2011","journal-title":"Nature"},{"key":"ref_229","first-page":"E2261","article-title":"Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nm1204","article-title":"Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome","volume":"11","author":"Scaffidi","year":"2005","journal-title":"Nat. Med."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jpeds.2004.10.064","article-title":"Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: Clues to the biology of premature atherosclerosis in Hutchinson-Gilford Progeria Syndrome","volume":"146","author":"Gordon","year":"2005","journal-title":"J. Pediatr."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCULATIONAHA.117.030856","article-title":"Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome","volume":"138","author":"Hamczyk","year":"2018","journal-title":"Circulation"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/mgme.2000.3092","article-title":"Familial partial lipodystrophy: A monogenic form of the insulin resistance syndrome","volume":"71","author":"Hegele","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/CRD.0000000000000014","article-title":"Antihyperlipidemic therapies targeting PCSK9","volume":"22","author":"Weinreich","year":"2014","journal-title":"Cardiol. Rev."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/en.2015-1624","article-title":"Effect of Leptin Replacement on PCSK9 in ob\/ob Mice and Female Lipodystrophic Patients","volume":"157","author":"Levenson","year":"2016","journal-title":"Endocrinology"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/2047487319839179","article-title":"Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk","volume":"27","author":"Cesaro","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2016.06.015","article-title":"Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol","volume":"251","author":"Enebakk","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/14740338.2019.1644317","article-title":"Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment","volume":"18","author":"Lagathu","year":"2019","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11883-015-0493-x","article-title":"Treatment of Dyslipidemia in HIV","volume":"17","author":"Sekhar","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/15284336.2016.1261073","article-title":"Comparative effectiveness of tenofovir in HIV-infected treatment-experienced patients: Systematic review and meta-analysis","volume":"18","author":"Ewald","year":"2017","journal-title":"HIV Clin. Trials"},{"key":"ref_241","first-page":"40","article-title":"Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy","volume":"46","author":"Lattanzi","year":"2009","journal-title":"J. Med. Genet."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"M111.008094","DOI":"10.1074\/mcp.M111.008094","article-title":"Proteomic profiling of adipose tissue from Zmpste24-\/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing","volume":"10","author":"Peinado","year":"2011","journal-title":"Mol. Cell Proteom."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/COH.0b013e32814b1638","article-title":"Adipocyte dysfunction in response to antiretroviral therapy: Clinical, tissue and in-vitro studies","volume":"2","author":"Caron","year":"2007","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"9948","DOI":"10.18632\/aging.205078","article-title":"Senescence-associated inflammation and inhibition of adipogenesis in subcutaneous fat in Werner syndrome","volume":"15","author":"Sawada","year":"2023","journal-title":"Aging"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/febs.15061","article-title":"Regulation of inflammation as an anti-aging intervention","volume":"287","author":"Neves","year":"2020","journal-title":"FEBS J."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/jdv.18225","article-title":"Atopic dermatitis: Pathomechanisms and lessons learned from novel systemic therapeutic options","volume":"36","author":"Bieber","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Liu, C., Arnold, R., Henriques, G., and Djabali, K. (2019). Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells. Cells, 8.","DOI":"10.3390\/cells8101276"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Arnold, R., Vehns, E., Randl, H., and Djabali, K. (2021). Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147474"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"111078","DOI":"10.1016\/j.intimp.2023.111078","article-title":"Metformin potentiates immunosuppressant activity and adipogenic differentiation of human umbilical cord-mesenchymal stem cells","volume":"124","author":"Bajetto","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"16026","DOI":"10.1038\/npjamd.2016.26","article-title":"Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells","volume":"2","author":"Egesipe","year":"2016","journal-title":"NPJ Aging Mech. Dis."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.celrep.2016.10.040","article-title":"Rapamycin Reverses Metabolic Deficits in Lamin A\/C-Deficient Mice","volume":"17","author":"Liao","year":"2016","journal-title":"Cell Rep."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.4081\/ejh.2011.e36","article-title":"Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria","volume":"55","author":"Cenni","year":"2011","journal-title":"Eur. J. Histochem."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"755","DOI":"10.18632\/aging.100680","article-title":"Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics","volume":"6","author":"Cenni","year":"2014","journal-title":"Aging"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ajpath.2018.11.013","article-title":"Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health","volume":"189","author":"Wipperman","year":"2019","journal-title":"Am. J. Pathol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1101\/gad.197954.112","article-title":"Nuclear lamina defects cause ATM-dependent NF-\u03baB activation and link accelerated aging to a systemic inflammatory response","volume":"26","author":"Osorio","year":"2012","journal-title":"Genes Dev."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1532-5415.2011.03570.x","article-title":"Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals","volume":"59","author":"Giovannini","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","article-title":"Tocilizumab: A Review in Rheumatoid Arthritis","volume":"77","author":"Scott","year":"2017","journal-title":"Drugs"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"e13285","DOI":"10.1111\/acel.13285","article-title":"Interleukin-6 neutralization ameliorates symptoms in prematurely aged mice","volume":"20","author":"Squarzoni","year":"2021","journal-title":"Aging Cell"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1701329","article-title":"Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides","volume":"377","author":"Graham","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/14712598.2016.1196182","article-title":"Anti-sense oligonucleotide therapies for the treatment of hyperlipidaemia","volume":"16","author":"Wierzbicki","year":"2016","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/imr.12375","article-title":"Nucleic acid-sensing TLRs and autoimmunity: Novel insights from structural and cell biology","volume":"269","author":"Pelka","year":"2016","journal-title":"Immunol. Rev."},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Ruda, V.M., Chandwani, R., Sehgal, A., Bogorad, R.L., Akinc, A., Charisse, K., Tarakhovsky, A., Novobrantseva, T.I., and Koteliansky, V. (2014). The roles of individual mammalian argonautes in RNA interference in vivo. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101749"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4155\/fmc.15.144","article-title":"Oligonucleotide therapeutics: Chemistry, delivery and clinical progress","volume":"7","author":"Sharma","year":"2015","journal-title":"Future Med. Chem."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2005.04.064","article-title":"Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: A PROVE IT-TIMI 22 substudy","volume":"46","author":"Wiviott","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3132\/dvdr.2008.046","article-title":"The Residual Risk Reduction Initiative: A call to action to reduce residual vascular risk in dyslipidaemic patient","volume":"5","author":"Fruchart","year":"2008","journal-title":"Diab. Vasc. Dis. Res."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"104413","DOI":"10.1016\/j.phrs.2019.104413","article-title":"A new dawn for managing dyslipidemias: The era of rna-based therapies","volume":"150","author":"Macchi","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/14779072.2018.1487290","article-title":"The effect of volanesorsen treatment on the burden associated with familial chylomicronemia syndrome: The results of the ReFOCUS study","volume":"16","author":"Arca","year":"2018","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1166\/jbn.2011.1313","article-title":"Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids","volume":"7","author":"Nimesh","year":"2011","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_271","doi-asserted-by":"crossref","unstructured":"Mirzaei, S., Gholami, M.H., Ang, H.L., Hashemi, F., Zarrabi, A., Zabolian, A., Hushmandi, K., Delfi, M., Khan, H., and Ashrafizadeh, M. (2021). Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy. Cells, 10.","DOI":"10.3390\/cells10123348"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40005-021-00553-9","article-title":"Lipid-based nanoparticles for photosensitive drug delivery systems","volume":"52","author":"Shim","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.gt.3302699","article-title":"Genospheres: Self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery","volume":"13","author":"Hayes","year":"2006","journal-title":"Gene Ther."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/17425247.2019.1669558","article-title":"Lipid-based nanoparticle formulations for small molecules and RNA drugs","volume":"16","author":"Ickenstein","year":"2019","journal-title":"Expert. Opin. Drug Deliv."},{"key":"ref_275","first-page":"1028","article-title":"Nanocarriers for delivery of siRNA as gene silencing mediator","volume":"21","year":"2022","journal-title":"EXCLI J."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/1061186021000066246","article-title":"A lipid-based delivery system for antisense oligonucleotides derived from a hydrophobic complex","volume":"10","author":"Wong","year":"2002","journal-title":"J. Drug Target."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ncb1971","article-title":"Ageing-related chromatin defects through loss of the NURD complex","volume":"11","author":"Pegoraro","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1002\/anie.201914751","article-title":"Systemic Brain Delivery of Antisense Oligonucleotides across the Blood-Brain Barrier with a Glucose-Coated Polymeric Nanocarrier","volume":"59","author":"Min","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1021\/acsabm.1c00334","article-title":"Polyamide Microsized Particulate Polyplex Carriers for the 2\u2019-OMethylRNA EFG1 Antisense Oligonucleotide","volume":"4","author":"Braz","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1080\/09205063.2017.1354670","article-title":"In vitro evaluation of antisense oligonucleotide functionalized core-shell nanoparticles loaded with \u03b1-tocopherol succinate","volume":"28","author":"Kilicay","year":"2017","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Mainini, F., and Eccles, M.R. (2020). Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy. Molecules, 25.","DOI":"10.3390\/molecules25112692"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.msec.2018.07.027","article-title":"Polyester-based nanoparticles for nucleic acid delivery","volume":"92","author":"Zhao","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/gt.2014.38","article-title":"Targeting adipose tissue via systemic gene therapy","volume":"21","author":"Hinkle","year":"2014","journal-title":"Gene Ther."},{"key":"ref_288","doi-asserted-by":"crossref","unstructured":"Uhrig-Schmidt, S., Geiger, M., Luippold, G., Birk, G., Mennerich, D., Neubauer, H., Grimm, D., Wolfrum, C., and Kreuz, S. (2014). Gene delivery to adipose tissue using transcriptionally targeted rAAV8 vectors. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0116288"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.omtm.2022.09.014","article-title":"Gene therapy restores adipose tissue and metabolic health in a pre-clinical mouse model of lipodystrophy","volume":"27","author":"Sommer","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/CIRCULATIONAHA.117.031335","article-title":"Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3","volume":"137","author":"Chadwick","year":"2018","journal-title":"Circulation"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1172\/JCI27820","article-title":"Good news in the nuclear envelope: Loss of lamin A might be a gain","volume":"116","author":"Scaffidi","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1073\/pnas.1111780109","article-title":"Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA","volume":"109","author":"Jung","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_293","first-page":"1826","article-title":"miRNA-9 expression is upregulated in the spinal cord of G93A-SOD1 transgenic mice","volume":"6","author":"Zhou","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.stem.2011.04.019","article-title":"Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs","volume":"8","author":"Liu","year":"2011","journal-title":"Cell Stem Cell"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8020\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:21:39Z","timestamp":1760109699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":294,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25158020"],"URL":"https:\/\/doi.org\/10.3390\/ijms25158020","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]}}}